Market Closed -
Other stock markets
|
|
After market 02:11:20 pm | ||
23.66 EUR | 0.00% | 23.82 | +0.68% |
Nov. 30 | Revenio Group Seeks M&A Opportunities | CI |
Nov. 30 | Transcript : Revenio Group Oyj - Analyst/Investor Day | CI |
Sales 2023 * | 95.39M 103M | Sales 2024 * | 103M 111M | Capitalization | 629M 679M |
---|---|---|---|---|---|
Net income 2023 * | 18M 19.41M | Net income 2024 * | 22M 23.73M | EV / Sales 2023 * | 6,41x |
Net cash position 2023 * | 17.38M 18.75M | Net cash position 2024 * | 29.75M 32.09M | EV / Sales 2024 * | 5,80x |
P/E ratio 2023 * | 33,2x | P/E ratio 2024 * | 28,3x | Employees | 214 |
Yield 2023 * | 1,63% | Yield 2024 * | 1,76% | Free-Float | 78.67% |
More Fundamentals
* Assessed data
More news
More press releases
1 day | +0.25% | ||
1 week | -4.75% | ||
Current month | +2.42% | ||
1 month | +2.16% | ||
3 months | +3.59% | ||
6 months | -24.12% | ||
Current year | -38.70% |
1 week
22.40
25.30

1 month
22.36
25.48

Current year
17.51
41.50

1 year
17.51
41.50

3 years
17.51
72.00

5 years
12.10
72.00

10 years
3.77
72.00

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 2020 | |
Director of Finance/CFO | 43 | 2015 | |
Ari Isomäki
COO | Chief Operating Officer | 57 | 2016 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 55 | 2020 | |
Director/Board Member | 59 | 2016 | |
Director/Board Member | 61 | 2007 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 117 M€ | 0.00% | ||
0.11% | 109 M€ | +5.60% | ||
0.11% | 191 M€ | +10.05% | ||
0.10% | 487 M€ | +8.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-05 | 23.66 | 0.00% | 23,705 |
23-12-04 | 23.66 | -1.74% | 39,187 |
23-12-01 | 24.08 | +4.24% | 61,294 |
23-11-30 | 23.1 | -8.77% | 285,133 |
23-11-29 | 25.32 | +1.93% | 56,296 |
Delayed Quote Nasdaq Helsinki, December 05, 2023 at 11:29 am EST
More quotes
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company's activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
Calendar
2024-02-14
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy

Mean consensus
BUY
Number of Analysts
4
Last Close Price
23.66EUR
Average target price
24.6EUR
Spread / Average Target
+3.97%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.70% | 679 M $ | |
-23.44% | 18 859 M $ | |
-22.45% | 4 439 M $ | |
-1.02% | 1 726 M $ | |
+82.28% | 1 640 M $ | |
+0.78% | 1 238 M $ | |
-34.76% | 1 195 M $ | |
-33.69% | 946 M $ | |
-26.20% | 384 M $ | |
+83.02% | 313 M $ |